AJHP Articles

• Formea CM, Weiss WT, McCluskey SV. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use. Am J Health Syst Pharm. 2008;65:1266-1269.
• Sweet BV, Tamer HR, Siden R, et al. Improving investigational drug service operations through development of an innovative computer system. Am J Health Syst Pharm. 2008;65:969-973.
• Tamer HR, Shehab N. Using preprinted medication order forms to improve the safety of investigational drug use. Am J Health Syst Pharm. 2006;63:1022-1028.
• Tamer HR, Shehab N. Dispensing investigational drugs: Regulatory issues and the role of the investigational drug service. Am J Health Syst Pharm. 2004;61:1882-1884.
• LaFleur J, Tyler LS, Sharma RR. Economic benefits of investigational drug services at an academic institution. Am J Health Syst Pharm. 2004;61:27-32.
• Tamer HR, Sweet BV. Compounding pharmaceuticals for investigational use. Am J Health Syst Pharm. 2002;59:1716-1719.
• Siden R, Tankanow RM, Tamer HR. Understanding and preparing for clinical drug trial audits. Am J Health Syst Pharm. 2002;59:2301.
• McDonagh MS, Miller SA, Naden E. Costs and savings of investigational drug services. Am J Health Syst Pharm. 2000;57:78-79.
  

ASHP Meeting Presentations

• Handling Investigational Drugs 101: Tips of the Trade from Experienced Investigational Drug Service Practitioners (Presented at 2008 Midyear Clinical Meeting) (Handout [PDF])
• Considerations and Opportunities for Your Investigational Drug Service (Presented at 2007 Midyear Clinical Meeting) (Handout [PDF])
• Managing Clinical Research and the Investigational Drug Service (Presented at 2006 Midyear Clinical Meeting)  (Handout [PDF])

Other Articles and Presentations

• Mark SM, Weber RJ. Advanced practice programs in hospital pharmacy: investigational drug services.  Hosp Pharm. 2008;43(2):143–148.
• Duke University Investigational Drug Services Overview